For more information, contact Joseph Saba at Joseph.Saba@axiosint.com.
Every Axios' strategy aims to deliver significant, measurable results. For this reason, research is a key component of our comprehensive access approach. By capturing and integrating locally-relevant indicators, Axios aims to create a foundation in which to measure success, support strategic decisions and optimize results along the way.
Patient and Market Intelligence Analysis
Axios’ rigorous epidemiological studies seek to understand behaviors, trends and patterns to garner useful insights driving patient and stakeholder decisions. Our research teams comprise both quantitative and qualitative researchers and subject-matter access specialists to ensure a well-balanced methodology and analysis.
Ability and Willingness to Pay & Prescribe Studies
In addition to ability to pay, patient and physician perception of product value plays an important role in product-purchase decisions in out-of-pocket markets. For this reason, Axios has developed a unique methodology that assesses both ability and willingness to pay and prescribe. Together, this assessment provides a more comprehensive understanding of the real market potential to help inform and shape both commercial and access strategy decisions.
Direct Distribution Platforms
In markets with limited to no existing commercial presence or distribution network, Axios’ direct distribution approach allows manufacturers to minimize investment until market viability is determined. We make this possible by establishing regional distribution hubs and coordinating delivery directly to the institution. As patient numbers increase, this model allows manufacturers to then make more informed market investment decisions.
Axios utilizes its proprietary methodologies to assess market reality and real product value in self-pay markets in order to identify and recommend locally-relevant and sustainable pricing strategies. Axios’ pricing approach is unique in that it considers a comprehensive range of market dynamic factors that could impact market potential and marketing effectiveness – including both ability to pay and willingness to pay and prescribe.